According to the results of a phase II, randomized study published in the New England Journal of Medicine, neratinib may effectively treat women with HER2-positive, hormone receptor-negative breast cancer.
Two years ago, I became ONS’s third chief executive officer and the staff partner to a Board of Directors that had a clear vision for a system that marches. If, as a member, you feel that ONS has undergone many changes in the past two years, you are correct.
When we talk about advocating for patients, whether it’s as an oncology nurse or an oncology social worker, we’re talking about optimal care and quality of life. You could have the greatest treatment in the world, but if your patient doesn’t have transportation to get to that treatment, what’s the point?
Nurse navigators are advocating for patients in institutions across the country, setting an example for what oncology nurses at any level can do to help their patients through the cancer journey.
The outcome of the 2016 presidential election will usher in a number of changes, as a new administration enters the White House for the first time in eight years. A large focus for both Republicans and Democrats will be on the healthcare industry and its accompanying details.
Until 2011, no effective therapeutic options existed for advanced thyroid cancer. However, thanks to clinical studies that have improved the understanding of thyroid cancer’s molecular basis, four kinase inhibitors were approved by the U.S. Food and Drug Administration.
Increasing weight during treatment may indicate early clinical benefit in patients with non-small cell lung cancer (NSCLC), according to the results of a study published in the Annals of Oncology.
